More about

Neurorehabilitation

News
February 21, 2025
3 min read
Save

Q&A: Stroke rehabilitation guideline helps physicians 'provide holistic care' for veterans

With a new clinical practice guideline, primary care providers can offer the best stroke rehabilitation care possible to service members and veterans, according to an expert.

News
May 21, 2024
1 min read
Save

Enveric, MindBio partner to advance psilocin prodrugs for mental health disorders

Enveric Biosciences announced it has signed a nonbinding term sheet to out-license a class of novel psilocin prodrugs to MindBio Therapeutics, an agreement that could yield more than $66 million in sales.

News
May 14, 2024
1 min read
Save

Positive efficacy results reported in phase 3 study of schizophrenia injectable

Teva Pharmaceuticals and Medincell have announced positive efficacy results from the phase 3 SOLARIS clinical trial evaluating an investigational, monthly subcutaneous injectable in adults with schizophrenia.

News
April 10, 2024
1 min read
Save

Nexalin to increase production of in-home, noninvasive deep brain stimulation device

A Houston-area neurohealth company announced completion of a full production test run, along with usability, feasibility design verification and electrical safety testing for its noninvasive, frequency-based deep brain stimulation device.

News
July 21, 2023
4 min read
Save

Neurologist partners with PCPs to elevate care for patients with mental illness

We are in a crisis when it comes to mental health in Alabama. According to the National Alliance on Mental Health, one in five adults in the state lives with mental illness.

News
June 20, 2023
1 min read
Save

Venous manometry could aid idiopathic intracranial hypertension diagnosis

AUSTIN, Texas — Venous manometry and neuroimaging may provide additional value when diagnosing patients who do not meet criteria for idiopathic intracranial hypertension, according to a poster presented here.

News
June 13, 2023
1 min read
Save

FDA clears OCD motor threshold cap for transcranial magnetic stimulation system

The FDA has granted 510(k) clearance to Neuronetics Inc. for its obsessive-compulsive disorder motor threshold cap technology for NeuroStar Advanced Therapy for Mental Health.

News
May 30, 2023
2 min read
Save

Pro-inflammatory diet linked to relapse rate, MRI marker in patients with MS

Consuming a pro-inflammatory diet was associated with higher risk for relapse and greater FLAIR lesion volume in the periventricular region in adults with MS, according to research in the Multiple Sclerosis Journal.

News
April 06, 2023
2 min read
Save

Speed-based cognitive exercises may reduce likelihood of falls in high-risk older adults

Speed of processing training reduced the risk for future falls over 10 years in high-risk older adults, while reasoning and memory training did not reduce the likelihood of future falls in this population, according to research.

News
February 03, 2023
3 min read
Save

Q&A: Insurer to address health system’s ‘blind spot’ by supporting psychedelic treatment

With a rising number of clinical studies demonstrating the potential benefits of psychedelic treatments for a wide range of behavioral health conditions, insurance plan provider Enthea aims to expand employer funding for these services.

View more